Recently, increasing numbers of rare pathogenic genetic variants have been identified that
are associated with variably elevated risks of a range of neurodevelopmental outcomes …

The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

The clinical features of 22q11. 2 deletion syndrome include virtually every organ of the body.
This review will focus on the immune system and the differences related to deletion …

Abstract 22q11. 2 deletion syndrome (22q. 11.2 DS) might be one of the strongest genetic
risk factors for psychosis, but robust estimates of prevalence and incidence of psychotic …

The prevalence of psychotic disorders in individuals with 22q11. 2 Deletion Syndrome
(22q11DS) reaches 25–35% in young adulthood and may provide a neurogenetic model for …

Abstract While the recurrent 22q11. 2 deletion is one of the strongest genetic risk factors for
schizophrenia (SCZ), variability of its associated neuropsychiatric endophenotypes reflects …

Copy number variants, such as duplications and hemizygous deletions at chromosomal loci
of up to a few million base pairs, are highly associated with psychiatric disorders …

Schizophrenia is an illness characterized by positive symptoms, negative symptoms, and
cognitive impairments. Cognitive impairments occur before the onset of psychosis and could …

BackgroundGenotype-first and within-family studies can elucidate factors that contribute to
psychiatric illness. Combining these approaches, we investigated the patterns of influence of …

The role of genetic variability in dementia with Lewy bodies (DLB) is now indisputable;
however, data regarding copy number variation (CNV) in this disease has been lacking …